Ginkgo BioworksDNA

紐約證券 · USD
8.91
+0.14
(+1.60%)
收盤 12/25 01:59 (UTC+8)
盤後 
8.86 
8.86 
(-0.56%)
12/25 01:59 (UTC+8)

財務數據

損益表

loading
載入中...
icon
  • 0.81
  • 0.55
  • 0.35
  • 0.38
  • 0.56
  • 0.89
  • 0.44
  • 0.48
  • 0.50
  • 0.39
icon
  • -0.17
  • -31.20
  • -37.30
  • 9.18
  • 48.13
  • 58.43
  • -50.76
  • 10.20
  • 2.66
  • -21.71
  • icon
    營業收入(億)
  • icon
    季增長率(%)
單位:美元千元
年季
2025/Q3
2025/Q2
2025/Q1
2024/Q4
2024/Q3
2024/Q2
2024/Q1
2023/Q4
2023/Q3
2023/Q2
營業收入淨額
38,837
49,604
48,318
43,847
89,046
56,206
37,944
34,755
55,430
80,568
營業成本
12,80214,82212,0479,62212,00313,7219,2026,6116,92318,096
營業毛利
26,035
34,782
36,271
34,225
77,043
42,485
28,742
28,144
48,507
62,472
營業費用
116,052100,323-----206,261334,900246,623
研發費用
69,35353,37070,92376,37777,006134,221136,457117,038156,662144,282
推銷及管理費用
44,95443,27949,04357,29752,29266,28570,28789,22382,028102,341
非經常性項目費用
1,7453,6745,2734,1572,94964,924--96,210-
其他營業費用
----------
營業利益
-90,017
-65,541
-88,968
-103,606
-55,204
-222,945
-178,002
-178,117
-286,393
-184,151
其他收入及費用
9,2634,958-1,901-4,159-1,5745,95412,122-32,563-16,52010,970
利息費用
---94---93--
稅前純益
-80,754
-60,583
-90,869
-107,859
-56,778
-216,991
-165,880
-211,892
-302,913
-173,248
所得稅
1-28388-325-37519031-198-2267
稅後純益
-80,755
-60,300
-90,957
-107,534
-56,403
-217,181
-165,911
-211,694
-302,891
-173,315
基本每股稅後盈餘(元)
-1.45-1.10-1.68-2.00-1.08-0.11-0.08--0.16-0.09
稀釋每股稅後盈餘(元)
-1.45-1.09-1.68-1.96-1.02-0.11-0.08-0.11-0.15-0.09
基本平均股數(千股)
55633.0054858.0054241.0053814.0052240.002054801.002004458.00-1950800.001933437.00
稀釋平均股數(千股)
55633.0054858.0054241.0053814.0052246.002055023.002005334.00-1950800.001933437.00
還原基本每股稅後盈餘(元)
-1.45-1.10-1.68-2.00-1.08-4.23-3.31--6.21-3.60
還原稀釋每股稅後盈餘(元)
-1.45-1.09-1.68-1.96-1.02-4.24-3.32-4.28-6.09-3.60
還原基本平均股數(千股)
55,63354,85854,24153,81452,24051,37050,111-48,77048,335
還原稀釋平均股數(千股)
55,63354,85854,24153,81452,24651,37550,133-48,77048,335
EBITDA(千元)
-69,088-44,790-75,503-92,113-39,609-199,661-153,011-197,915-281,853-155,027

大家都在看

HOT